Related Experiment Video
Updated: Sep 18, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis and Impact of COVID-19 on Spread of Epidemics in Kazakhstan
Zhandarbek Bekshin1, Albert Askarov2, Yergali Abduraimov3
1Republican Collection of Microorganisms, Astana 010000, Kazakhstan.
Abstract:
This study examines the epidemiological situation of tuberculosis (TB) in the regions of the Republic of Kazakhstan over the past seven years (2018-2024), which cover the before-, during- and after-COVID-19 periods, with a focus on the risks of its emergence and spread. The analysis revealed that while TB incidence is declining, mortality remains high in the before- and during-COVID-19 periods, indicating a general decline in population health. The concentration of TB incidence in relation to geographic location was mainly in the northern, western and southern regions. Before COVID-19, TB incidence reached 48.2 cases and mortality reached a maximum of 2.4 cases per 100,000 people. In 2024, the incidence and mortality of tuberculosis significantly decreased to 33.5 (30.5%) and 1.0 (58.3%), respectively, reflecting an improvement in health indicators in the post-pandemic period. In the after-COVID-19 period, in regions with high unemployment, the incidence was higher than in the before- and during-COVID-19 periods. Nevertheless, it is important that the trend in tuberculosis incidence shows positive improvement after the COVID-19 period. In addition, a comparative analysis of tuberculosis incidence trends in different age groups and social factor groups shows that the adult population remains the most vulnerable category among the general population. The above-listed factors, as well as our analysis of tuberculosis incidence, shows that TB incidence does not always correlate with the level of vaccination in different regions of Kazakhstan, indicating a multifactorial influence on the tuberculosis epidemic.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders